College Fellows and Staff

Professor Gurnell

Professor Mark Gurnell

Fellow in Medicine

Director of Studies in Medicine (Clinical) and Natural Sciences (Biochemistry)

College Room: Dept. Endocrinology

College Tel: +44 1223 7 61257

Email:

Email:

Web: Department

Personal Biography

Clinical SubDean, University of Cambridge School of Clinical Medicine

Professor of Clinical Endocrinology & Honorary Consultant Physician, Department of Medicine & Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge & Addenbrooke’s Hospital, Cambridge, UK

Mark Gurnell is Professor of Clinical Endocrinology at the University of Cambridge. He is clinical lead for adrenal and pituitary services at Addenbrooke’s Hospital and the East of England, and co-directs a national & international referral service for patients with complex/atypical thyroid function tests.

His research is focussed on the development of novel approaches to the investigation and management of adrenal, pituitary and thyroid disorders, which can be rapidly translated in to clinical practice. His specific interests include:

  • molecular imaging in pituitary adenomas and primary aldosteronism
  • genetic and acquired disorders of the hypothalamic-pituitary-thyroid axis
  • acromegaly
  • the role of the endocrine system in risk taking & financial decision making

As SubDean in the School of Clinical Medicine, he leads the Assessment programme in Cambridge, and is chair of the UK Medical Schools Council Assessment Alliance Board.

Selected Publications

Tan CL, Alavi SA, Baldeweg SE, Belli A, Carson A, Feeney C, Goldstone AP, Greenwood R, Menon DK, Simpson HL, Toogood AA, Gurnell M*,Hutchinson PJ. The screening and management of pituitary dysfunction following traumatic brain injury in adults: British Neurotrauma Group guidance.J Neurol Neurosurg Psychiatry, 2017 Aug 31. Pii: jnnp-2016-315500. Doi:10.1136/jnnp-2016-315500. PMID:28860331

Coates J & Gurnell M. Combining field work and laboratory work in the study of financial risk-taking. Hormones and Behavior,2017, 92:13-19. PMID:28174099.

Koulouri O, Hoole AC, English P, Allinson K, Antoun N, Cheow HK, Burnet NG, Donnelly N, Mannion RJ, Gurnell M.Localisation of an occult thyrotropinoma with 11C-Methionine PET-CT before and after somatostatin analogue therapy. Lancet Diabetes Endocrinol, 2016, 4(12):1050. PMID:27777050.

Kandasamy N, Garfinkel SN, Page L, Hardy B, Critchley H, Gurnell M*,Coates JM. Interoceptive ability predicts survival on a London trading floor. Scientific Reports,2016 Sep 19;6:32986. doi: 10.1038/srep32986. PMID:27641692.

Koulouri O, Kandasamy N, Hoole AC, Gillett D, Heard S, Powlson AS, O'Donovan DG, Annamalai AK, Simpson H, Akker SA, Aylwin S, Brooke A, Buch H, Levy M, Martin NM, Morris D, Parkinson C, Tysome JR, Santarius T, Donnelly NA, Buscombe J, Boros I, Smith R, Aigbirhio F, Antoun NM, Burnet NG, Cheow H, Mannion RJ, Pickard JD, Gurnell M.Successful treatment of residual pituitary adenoma in persistent acromegaly following localisation by 11C-methionine PET-CT co-registered with MRI. Eur J Endocrinol,2016, 175(5):485-498. PMID:27562400.

Teo AED,  Garg S, Shaikh LH, Zhou J, Karet Frankl FE, Gurnell M,Happerfield L, Marker A, Bienz M, Azizan EAB, Brown MJ. Pregnancy, primary aldosteronism and somatic CTNNB1 mutations in the adrenal. N Engl J Med, 2015, 373(15):1429-36. PMID:26397949.